IRIS
NAVARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.190
NA - Nord America 2.873
EU - Europa 1.321
SA - Sud America 402
Continente sconosciuto - Info sul continente non disponibili 142
AF - Africa 81
OC - Oceania 22
Totale 11.031
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.255
US - Stati Uniti d'America 2.722
CN - Cina 889
IT - Italia 589
HK - Hong Kong 433
BR - Brasile 298
VN - Vietnam 189
GB - Regno Unito 175
BD - Bangladesh 157
FR - Francia 145
DE - Germania 101
NL - Olanda 79
CA - Canada 77
IN - India 77
MX - Messico 50
FI - Finlandia 38
AR - Argentina 33
ID - Indonesia 30
ES - Italia 29
TR - Turchia 26
ZA - Sudafrica 26
JP - Giappone 24
AT - Austria 23
EC - Ecuador 21
AU - Australia 19
UA - Ucraina 19
CO - Colombia 18
RU - Federazione Russa 18
PL - Polonia 17
EG - Egitto 13
PK - Pakistan 13
CZ - Repubblica Ceca 11
DK - Danimarca 11
LT - Lituania 11
IQ - Iraq 10
PE - Perù 10
CL - Cile 9
PH - Filippine 9
SA - Arabia Saudita 9
TN - Tunisia 9
IR - Iran 7
JM - Giamaica 7
LB - Libano 7
SE - Svezia 7
UZ - Uzbekistan 7
BG - Bulgaria 6
IE - Irlanda 6
LY - Libia 6
MA - Marocco 6
MY - Malesia 6
PY - Paraguay 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
MD - Moldavia 5
BE - Belgio 4
DZ - Algeria 4
GT - Guatemala 4
HN - Honduras 4
IL - Israele 4
OM - Oman 4
CR - Costa Rica 3
EE - Estonia 3
KE - Kenya 3
KZ - Kazakistan 3
RS - Serbia 3
TH - Thailandia 3
TL - Timor Orientale 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
ET - Etiopia 2
GH - Ghana 2
HR - Croazia 2
LK - Sri Lanka 2
LV - Lettonia 2
NC - Nuova Caledonia 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HT - Haiti 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LC - Santa Lucia 1
MG - Madagascar 1
MK - Macedonia 1
Totale 10.875
Salva come PNG Salva come JPEG
Città #
San Jose 767
Singapore 613
Ashburn 469
Hong Kong 426
Rome 336
Dallas 268
Hefei 258
Beijing 239
Council Bluffs 232
Columbus 153
Boardman 136
London 121
Lauterbourg 115
Shanghai 83
Ho Chi Minh City 76
Amsterdam 56
Santa Clara 56
Munich 50
New York 45
Los Angeles 43
Hanoi 36
Mexico City 29
Turku 23
São Paulo 22
Toronto 22
Milan 20
Naples 19
Brooklyn 18
Pune 18
Washington 18
Ankara 17
Tokyo 17
Atlanta 16
Bari 16
San Francisco 16
Frankfurt am Main 15
Warsaw 15
Haiphong 14
Helsinki 13
Las Vegas 13
Buffalo 12
Chennai 12
Hangzhou 12
Chicago 11
Johannesburg 10
Montreal 10
Nuremberg 10
Rio de Janeiro 10
Boston 9
Changsha 9
Jinan 9
Seattle 9
Vienna 9
Charlotte 8
Guangzhou 8
Jaguariúna 8
Orem 8
Qingdao 8
West Jordan 8
Brasília 7
Leicester 7
Turin 7
Baghdad 6
Guayaquil 6
Melbourne 6
Paris 6
Quito 6
Tripoli 6
Cape Town 5
Champlin 5
Da Nang 5
Dammam 5
Denver 5
Dublin 5
Hải Dương 5
Madrid 5
Manaus 5
Miami 5
Philadelphia 5
Pisa 5
Prague 5
Shijiazhuang 5
Tashkent 5
Amman 4
Beirut 4
Belo Horizonte 4
Biên Hòa 4
Brno 4
Bắc Giang 4
Cairo 4
Calgary 4
Chaozhou 4
Chengdu 4
Cotia 4
Guarulhos 4
Guatemala City 4
Hyderabad 4
Kongens Lyngby 4
Lahore 4
Manchester 4
Totale 5.299
Salva come PNG Salva come JPEG
Nome #
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 228
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 222
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 222
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 219
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 211
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 208
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 206
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 198
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 197
Leptin in immuno-rheumatological diseases 192
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 177
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 171
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 169
Adult-onset Still's disease with elderly onset: results from a multicentre study 167
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 167
Personal attitudes and denialist views about the COVID-19 pandemic in Italy: a national survey 147
A longitudinal study on caring behaviors of Italian nursing students 145
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 143
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 142
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 124
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 123
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 121
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 120
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 120
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 118
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 118
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 117
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 116
Beauty is not perfection: what Leonardo’s Lady with an Ermine can suggest to aesthetic surgery 115
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 111
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 110
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 107
Cannabinoids in Autoimmune and Rheumatic Diseases 104
Leptin in autoimmune mechanisms of systemic rheumatic diseases 104
Development and implementation of the AIDA International Registry for patients with Behçet's disease 103
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 100
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 98
Polypharmacy is a determinant of hospitalization in Parkinson's disease 98
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 94
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 93
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 91
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 88
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 86
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 81
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 77
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 76
Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors 76
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 75
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 74
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 73
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 72
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 71
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 70
The Association of Olfactory Dysfunction, Frailty, and Mortality Is Mediated by Inflammation: Results from the InCHIANTI Study 68
Euthymic despite pain: the role of cognitive reappraisal and experiential avoidance in autoimmune inflammatory rheumatic diseases—a cross-sectional study 67
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 66
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 64
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort 64
Pathogenesis of Psoriatic Arthritis 63
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients 62
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 61
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 60
From pain catastrophising to multidimensional psychological distress: unravelling the complexity of difficult-to-treat psoriatic arthritis 60
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 60
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological Features 59
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 59
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 59
Phase angle could be a marker of microvascular damage in systemic sclerosis 59
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study 59
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry 57
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 57
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 57
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 57
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 56
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry 55
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 55
Necrobiosis-Lipoidica-Like Skin Lesions in a Patient with Non-Systemic Sarcoidosis 54
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 54
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 53
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 53
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 53
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 53
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 53
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 53
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 53
Development and Implementation of the AIDA International Registry for Patients With Still's Disease 52
Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future 52
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 52
LOW-DOSE ASPIRIN MAY HAVE A ROLE AS PRIMARY PROPHYLAXIS OF CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: EVIDENCE FROM AN ITALIAN MULTICENTRIC RETROSPECTIVE STUDY 52
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 51
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 51
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 51
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 51
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 51
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 51
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 50
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 50
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 50
Metabolic syndrome is associated with better quality of sleep in the oldest old: results from the "Mugello Study" 50
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 50
Totale 9.482
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 1 2 0 0 0 2 4 21 6 2 81
2022/2023165 1 0 5 4 60 0 6 5 6 7 63 8
2023/2024422 16 53 18 50 45 164 8 18 7 12 21 10
2024/20254.807 49 58 141 90 92 131 73 21 321 328 1.545 1.958
2025/20265.057 490 229 479 528 232 279 1.263 311 325 441 315 165
2026/2027461 94 367 0 0 0 0 0 0 0 0 0 0
Totale 11.031